On May 9th, the U.S. Department of Justice (DOJ) filed a lawsuit at the request of the U.S. Food and Drug Administration (FDA) against stem cell clinics currently performing surgical procedures involving autologous adipose tissue.

According to the FDA and the DOJ, even if this procedure is in the patient’s best interest and can improve their quality of life, they are no longer legally allowed to undergo such treatment.

If the FDA prevails in its attempt to stop physicians in the United States from performing these life-changing stem cell procedures, the thousands of patients nationwide who have benefitted from this holistic therapy will be the last to do so, and subsequent treatments will return to offshore clinics. This will greatly reduce the number of patients who can afford these kinds of life-changing therapies and will force autologous, adipose stem cell treatments back into the dark ages.